Skip to content
Crown Palace

Zimbabwe Turns Down ‘Unbalanced’ American Health Aid Package Because of Information Fears

Medical aid image
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has declined a major US health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' insistence on sensitive data.

This move was revealed following a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".

An official spokesperson later clarified that the US was seeking biological samples for scientific study and commercial purposes while refused to guarantee the resulting advantages from any future vaccines.

"We must now begin the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for more talks to find a deal acceptable to both sides so the country's critical HIV treatment initiative can continue.

Broader Context

Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court suspended a similar deal with the US following legal challenges were raised about the security of Kenyans' medical information.

Since resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing government-to-government deals to enhance openness and accountability.

Based on statements, 16 nations in Africa have to date agreed to similar health pacts, constituting more than $18.3bn in committed funds.

Details of the Declined Agreement

The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont commented.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to share its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might be developed from that provided information," his statement read.

"Put simply, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our citizens if a new health crisis arise."

Sovereignty and International Frameworks

He also said that the American exit from the global health body and its pursuit of one-on-one deals were upending systems already set up via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage future global health emergencies.

"This framework is intended to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We encourage further dialogue with our US partners on how subsequent co-operation might be structured in a manner that honours the independence and interests of both nations."

Health Experts Response

A leading public health body stated it recognised the official position, but recommended that talks need to persist given that much of the country's Aids initiatives depended on foreign aid.

"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can often be resolved through technical clarification and mutually agreed protections," it said.

This impasse underscores the continuing challenges between receiving much-needed international aid and protecting local interests in an ever more data-driven world.

JC
Written by

John Cruz

Hospitality expert and travel writer with over a decade of experience covering luxury hotels and event venues across Europe.

Crown Palace

Type to search articles.